← Leaderboards
Vernon E Walker
Lovelace Biomedical &Environmental Res
$4,118,864
Attributed
$4,118,864
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $670.5K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$4,118,864 · 3
By mechanism
R01$3,969,067 · 2
U01$149,797 · 1
Top collaborators
No co-investigators on record.
Most similar at Lovelace Biomedical &Environmental Res
Same institution · by research overlap
- Salina M Torres$58,620
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsGene MutationZidovudineTissue /Cell CultureAids TherapyReverse Transcriptase InhibitorsPolymerase Chain ReactionNucleoside AnalogCarcinogensHiv InfectionsCancer RiskDna DamageEmbryo /Fetus Cell /TissueEmbryo /Fetus Drug Adverse EffectMitochondrial Disease /DisorderLaboratory MouseCellular PathologyHuman Fetus TissueHuman SubjectHeart CellImmunocytochemistryElectron MicroscopyCord BloodDrug Interactions
Grant awards (9)
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug$73,963
U01 · FY2011 · CA · contact PI
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug$75,834
U01 · FY2010 · CA · contact PI
In utero NRTIs &mtDNA Changes in Cardiac/Vascular Cells$670,472
R01 · FY2005 · HL
In utero NRTIs &mtDNA Changes in Cardiac/Vascular Cells$735,075
R01 · FY2004 · HL
Mutagenesis of Single/Combined NRTI Drugs in Human Cells$401,284
R01 · FY2004 · CA
In utero NRTIs &mtDNA Changes in Cardiac/Vascular Cells$730,343
R01 · FY2003 · HL
Mutagenesis of Single/Combined NRTI Drugs in Human Cells$389,600
R01 · FY2003 · CA
In utero NRTIs &mtDNA Changes in Cardiac/Vascular Cells$663,880
R01 · FY2002 · HL
Mutagenesis of Single/Combined NRTI Drugs in Human Cells$378,413
R01 · FY2002 · CA